BCL2 and endometrial cancer: The study also revealed that the expression of miR-29b is associated with the increased sensitivity of endometrial cancer cells to cisplatin and the cisplatin-induced enhancement of apoptosis through the regulation of BAX and Bcl-2 expression [51].